PCA
AGN

Peddock Capital Advisors’s Allergan Inc AGN Stock Holding History

Peddock Capital Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-6,483
Closed -$1.49M – 254
2016
Q3 		$1.49M Buy
+6,483
New +$1.49M 0.92% 15
2015
Q1 		– Sell
-2,198
Closed -$467K – 103
2014
Q4 		$467K Buy
2,198
+102
+5% +$20.3K 0.38% 65
2014
Q3 		$373K Hold
2,096
– – 0.3% 71
2014
Q2 		$355K Buy
2,096
+280
+15% +$43.6K 0.27% 72
2014
Q1 		$225K Buy
+1,816
New +$221K 0.18% 83

Other funds holding AGN

FIM
Frontier Investment Management Dallas, Texas $1.62B AUM 1.86% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return
MMPW
Mitchell McLeod Pugh & Williams Mobile, Alabama $678M AUM 23.02% 1-Year Est. Return
HHAA
Henry H. Armstrong Associates Pittsburgh, Pennsylvania $1.03B AUM 4.23% 1-Year Est. Return
CAM
Cubic Asset Management Boston, Massachusetts $422M AUM 29.18% 1-Year Est. Return
LCP
Legacy Capital Partners Milwaukee, Wisconsin $304M AUM 20.42% 1-Year Est. Return
CI
Chartist Inc Seal Beach, California $139M AUM
DY
Dowling & Yahnke San Diego, California $2.15B AUM 10.82% 1-Year Est. Return
CIS
Connors Investor Services Wyomissing, Pennsylvania $1.08B AUM 31.31% 1-Year Est. Return

Peddock Capital Advisors's AGN Position: Q4 2016 in Review

Peddock Capital Advisors sold out of Allergan Inc (AGN) in Q4 2016, closing a stake of 6,483 shares — an estimated $1.49M sold.

Peddock Capital Advisors first reported a position in AGN in Q1 2014 and held it in 5 quarters. The position peaked at $1.49M in Q3 2016. 14 funds tracked by Wall St. Rank hold AGN as of Q4 2016.

  • Peddock Capital Advisors reported no remaining Allergan Inc position as of Q4 2016 after selling out during the quarter.
  • Peddock Capital Advisors sold 6,483 Allergan Inc shares in Q4 2016, an estimated $1.49M.
  • Peddock Capital Advisors first reported a position in Allergan Inc in Q1 2014 and held it in 5 quarters.
  • Peddock Capital Advisors's Allergan Inc position peaked at $1.49M in Q3 2016.
  • 14 funds tracked by Wall St. Rank held Allergan Inc as of Q4 2016.

Based on Peddock Capital Advisors's 13F filing for Q4 2016, filed 3 Feb 2017.